Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Stockholders' Equity, beginning balances at Dec. 31, 2020	$ 256,387	$ 3	$ 392,063		$ (135,679)
Stockholders' Equity, beginning balances (in shares) at Dec. 31, 2020		26,681,983
Issuance of common stock upon exercise of stock options and warrants	3,905		3,905
Issuance of common stock upon exercise of stock options and warrants (in shares)		646,417
Issuance of common stock upon initial public offering, net of issuance cost	115,090		115,090
Issuance of common stock upon initial public offering, net of issuance cost (in shares)		4,875,715
Issuance of common stock warrant	1,146		1,146
Stock-based compensation expense	13,799		13,799
Issuance of common stock - 2020 ESPP	433		433
Issuance of common stock - 2020 ESPP (in shares)		20,409
Vesting of common stock warrants issued for services	87		87
Net unrealized loss on marketable securities	(423)			$ (423)
Net loss	(71,317)				(71,317)
Stockholders' Equity, ending balances at Dec. 31, 2021	319,107	$ 3	526,523	(423)	(206,996)
Stockholders' Equity, ending balances (in shares) at Dec. 31, 2021		32,224,524
Issuance of common stock upon exercise of stock options and warrants	2,466		2,466
Issuance of common stock upon exercise of stock options and warrants (in shares)		291,629
Stock-based compensation expense	17,121		17,121
Issuance of common stock - 2020 ESPP	823		823
Issuance of common stock - 2020 ESPP (in shares)		110,474
Vesting of common stock warrants issued for services	87		87
Net unrealized loss on marketable securities	(773)			(773)
Net loss	(107,494)				(107,494)
Stockholders' Equity, ending balances at Dec. 31, 2022	$ 231,337	$ 3	$ 547,020	$ (1,196)	$ (314,490)
Stockholders' Equity, ending balances (in shares) at Dec. 31, 2022		32,626,627